Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LigaPASS™ System

K-Number: K261374 · 2026-05-27

Decision Date2026-05-27
Product CodeOWI
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

LigaPASS™ System is the device name listed in this FDA 510(k) record. The listed applicant is Medicrea International S.A.S. It received FDA 510(k) clearance on 2026-05-27 under 510(k) number K261374. The device is classified under product code OWI. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LigaPASS™ System?

LigaPASS™ System is a medical device that received FDA 510(k) clearance on 2026-05-27. The listed applicant is Medicrea International S.A.S. The 510(k) number is K261374.

When did LigaPASS™ System receive FDA 510(k) clearance?

LigaPASS™ System received FDA 510(k) clearance on 2026-05-27, under 510(k) number K261374.

Who is the listed applicant for LigaPASS™ System?

The FDA 510(k) record lists Medicrea International S.A.S as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LigaPASS™ System?

The FDA product code for LigaPASS™ System is OWI.

Related Devices (Code: OWI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.